Comparaison des caractéristiques et des pronostics des patients avec et sans cancer actif hospitalisés pour une infection à SARS-CoV-2

Archive ouverte

Fenioux, Charlotte | Allenbach, Yves | Vozy, Aurore | Salem, Joe-Élie | Maalouf, Georgina | Vieira, Matheus | Le Joncour, Alexandre | Benveniste, Olivier | Saadoun, David | Frère, Corinne | Campedel, Luca | Salem, Pierre | Gligorov, Joseph | Funck-Brentano, Christian | Cacoub, Patrice | Gougis, Paul

Edité par CCSD ; Elsevier -

International audience. Background: Patients with solid cancer or haematologic malignancies have been considered to be more susceptible to SARS-CoV-2 infection and to more often develop severe complications. We aimed to compare the differences in clinical features and outcomes of COVID-19 patients with and without cancer.Methods: This was a prospective observational cohort study of consecutive adult patients hospitalised in a COVID-19 unit at Pitié-Salpêtrière Hospital, Paris, France (NCT04320017).Results: Among the 262 patients hospitalised in a medical ward during the pandemics with a confirmed COVID-19 diagnosis, 62 patients had cancer. Clinical presentation, comorbidities, and outcomes were similar between cancer and non-cancer patients. However, cancer patients were more likely to have been contaminated while being hospitalised.Conclusions: Oncologic and non-oncologic patients hospitalised for COVID-19 shared similar outcomes in terms of death, admission in intensive care, or thrombosis/bleeding. They should benefit from the same therapeutic strategy as the general population during the COVID-19 pandemic.

• Description
• Sujet/Public
• Outil
• Outil d'anticipation
• Mémoire et thèse
• Gestion